Heart inflammation clues sought in rare heart disease

NCT ID NCT05209776

Recruiting now Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether inflammation inside the heart contributes to arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare heart condition. Researchers will measure inflammatory markers in blood and heart tissue from 80 participants, including people with ARVC and healthy controls. The goal is to understand the role of local inflammation in disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help clarify whether inflammation drives ARVC progression, potentially pointing toward new treatment targets.
What could go wrong: This is an early observational study with no treatment being tested. It only measures inflammatory markers, so it cannot prove cause or lead directly to a therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arrhythmogenic right ventricular cardiomyopathy Camurati-Engelmann Syndrome Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA

Contacts and locations

Locations

Toulouse University Hospital Center
RECRUITING

Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.